Trump Dumps Industry-Supported Trans-Pacific Partnership
Executive Summary
In an executive memorandum, President Trump formally pulled the US out of the Trans-Pacific Partnership (TPP) trade agreement that had been negotiated with 11 other countries and strongly supported by the device industry. Medtech industry groups tried to put a good face on things, saying they look forward to working with the new administration on bilaterial agreements to further open markets in Asia and elsewhere.
You may also be interested in...
Could Contentious IPR Trade Terms Bloat Healthcare Costs, Sink Pharma’s Image?
Intellectual property rights terms in various trade agreements could have serious ramifications not just on healthcare costs but also on the legitimate trade of generic drugs between developing nations, say some experts. Pharma’s image may be at stake too.
House Panel Plans Oversight On Device Tax, MACRA, Trade Negotiations
The US House Ways and Means Committee will focus oversight actions this Congress on Affordable Care Act issues including device tax repeal, Health and Human Services priorities – including implementation of provider payment reforms – and overseas trade negotiations, the panel agreed Feb. 14.
AdvaMed Tags China-Made Device Knock Offs As Concern At Federal Commission Hearing
U.S. device companies dealing in Asia worry about Chinese firms stealing American manufacturers’ intellectual property, then selling knock-offs of American devices that look similar, but are not as safe, AdvaMed’s executive VP of global strategies Ralph Ives told a U.S.-China trade commission April 3.